List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 344 studies with search of: "Ribavirin"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Peginterferon Alfa-2a and Ribavirin for Genotype 2 Chronic Hepatitis C: Duration and Ribavirin Dose Stratified by RVR
Condition: Chronic Hepatitis C
Interventions: Drug: Pegylated interferon alfa-2a + ribavirin;   Drug: Pegylated interferon alfa-2a + ribavirin;   Drug: Pegylated interferon alfa-2a + ribavirin;   Drug: Pegylated interferon alfa-2a + ribavirin;   Drug: Pegylated interferon alfa-2a + ribavirin
2 Recruiting Combination Therapy With Pegylated Interferon and Ribavirin in Patients With Chronic Hepatitis C Genotype 2 or 3 Infection Who Previously Have Relapsed After Therapy With Pegylated Interferon and Ribavirin
Condition: Chronic Hepatitis C
Interventions: Drug: Pegylated interferon alfa-2a and ribavirin;   Drug: Pegylated interferon alfa-2a and ribavirin;   Drug: Pegylated interferon alfa-2a and ribavirin
3 Recruiting Pegasys® Plus Ribavirin in Hemophilic Patients With Hepatitis C Virus Infection
Conditions: Hepatitis C;   Hemophilia
Interventions: Drug: PEGASYS® (Peginterferon Alfa-2a (40KD)) Plus COPEGUS® (Ribavirin);   Drug: PEGASYS® (Peginterferon Alfa-2a (40KD)) Plus COPEGUS® (Ribavirin)
4 Recruiting High Dose Versus Standard Dose of Ribavirin in Patients With Chronic Hepatitis C, Genotype 3
Condition: Chronic Hepatitis C
Interventions: Drug: Peginterferon alfa 2 A;   Drug: Peginterferon alfa 2 A, ribavirin + Epo Beta;   Drug: ribavirin;   Drug: ribavirin;   Drug: Peginterferon alfa 2;   Drug: ribavirin
5 Not yet recruiting TMC435-TiDP16-C205: A Phase II Study of TMC435 in Combination With Pegylated Interferon Alpha-2a and Ribavirin in Patients Infected With Genotype 1 Hepatitis C Virus Who Never Received Treatment
Condition: Hepatitis C
Interventions: Drug: TMC435;Placebo;Ribavirin;PegIFNalpha;   Drug: TMC435; Ribavirin; PegIFNalpha-2a;   Drug: Placebo; Ribavirin; PegIFNalpha-2a;   Drug: TMC435; Ribavirin; PegIFNalpha-2a;   Drug: TMC435; Placebo; Ribavirin; PegIFNalpha-2a
6 Recruiting Four Arms, Multicenter Study of Tailored Regimens With Peginterferon Plus Ribavirin for Genotype 2 Chronic Hepatitis C
Conditions: Chronic Hepatitis C;   Genotype
Interventions: Drug: pegylated interferon alpha 2a and plus ribavirin;   Drug: Pegylated interferon alfa-2a and ribavirin;   Drug: pegylated interferon alpha 2a and ribavirin;   Drug: pegylated interferon alpha 2a and ribavirin
7 Completed Study of Nitazoxanide, Peginterferon, and Ribavirin Combination Therapies in the Treatment of Chronic Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: Nitazoxanide;   Biological: Peginterferon alfa-2a;   Biological: Peginterferon alfa-2a;   Drug: Ribavirin;   Drug: Ribavirin
8 Completed Three Regimens of PEG-Intron Plus Ribavirin in Previously Untreated Chronic Hepatitis C, Genotype 2 or 3 (Study P03548AM2)(COMPLETED)
Condition: Hepatitis C, Chronic
Interventions: Biological: peginterferon alfa-2b (SCH 54031);   Drug: ribavirin (SCH 54031);   Biological: peginterferon alfa-2b (SCH 54031);   Drug: ribavirin (SCH 54031);   Biological: peginterferon alfa-2b (SCH 54031);   Drug: ribavirin (SCH 54031)
9 Recruiting Pegylated Interferon Plus Ribavirin in Treating Older Patients With Chronic Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: pegylated interferon alpha and plus ribavirin;   Drug: pegylated interferon alpha and plus ribavirin;   Drug: pegylated interferon alpha and plus ribavirin
10 Recruiting High-Dose Ribavirin in Treatment of Chronic Hepatitis C Genotype 1 or 4
Condition: Chronic Hepatitis C Genotype One or Four
Interventions: Drug: ribavirin;   Drug: ribavirin
11 Not yet recruiting Ribavirin for Hemorrhagic Fever With Renal Syndrome in Germany
Condition: Hemorrhagic Fever With Renal Syndrome
Intervention: Drug: Virazole (Ribavirin)
12 Recruiting Effect of Infliximab on the Efficacy of Peg-Intron/Ribavirin in Patients With Hepatitis C (Study P04257AM1)
Condition: Hepatitis C, Chronic
Interventions: Drug: Induction dose of (a) infliximab followed by combination of (b) pegylated interferon alfa-2b and (c) ribavirin;   Drug: Combination of (a) pegylated interferon alfa-2b and (b) ribavirin
13 Recruiting Pilot Comparison of Standard Antiviral Therapy With and Without 12 Weeks of Betaine in Genotype 1 Naive Patients
Condition: Chronic Hepatitis C
Interventions: Drug: Peginterferon alpha-2a and ribavirin;   Drug: Peginterferon alpha-2a , ribavirin and betaine
14 Recruiting Pegasys® Plus Ribavirin in Thalassemic Patients With Hepatitis C Virus Infection
Conditions: Hepatitis C;   Thalassemia
Intervention: Drug: PEGASYS® (Peginterferon Alfa-2a (40KD)) Plus COPEGUS® (Ribavirin)
15 Completed Extended Treatment With PEG-Intron and Rebetol in Patients With Genotype 1 Chronic Hepatitis C and Slow Virologic Response (Study P03685AM3)(COMPLETED)
Condition: Hepatitis C, Chronic
Interventions: Drug: Combination of pegylated interferon alfa-2b and ribavirin;   Drug: Combination of pegylated interferon alfa-2b and ribavirin
16 Recruiting The Efficacy of Peginterferon Plus Ribavirin Therapy for Chronic Hepatitis C Patients Concomitant With Hepatoma
Conditions: Chronic Hepatitis C;   Hepatocellular Carcinoma
Interventions: Drug: pegylated interferon alpha 2a and plus ribavirin;   Drug: pegylated interferon alpha 2a and plus ribavirin
17 Recruiting Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Malignancy Other Than Hepatocellular Carcinoma
Conditions: Chronic Hepatitis C;   Neoplasms
Interventions: Drug: pegylated interferon alpha 2a and plus ribavirin;   Drug: pegylated interferon alpha 2a and plus ribavirin
18 Completed A Randomized Trial of 24-Week Versus 48-Week Courses of Peginterferon Plus Ribavirin for HCV Genotype-1 Patients
Conditions: Chronic Hepatitis C;   Genotype
Interventions: Drug: pegylated interferon alpha 2a and ribavirin;   Drug: Pegylated interferon alfa-2a and ribavirin
19 Recruiting Randomized Trial of 24 or 48 Weeks of Peginterferon Alfa-2a Plus Ribavirin for HCV Genotype 1-Infected Patients
Condition: Chronic Hepatitis C
Interventions: Drug: Pegylated interferon alfa-2a plus ribavirin;   Drug: Pegylated interferon alfa-2a plus ribavirin
20 Active, not recruiting A Study of Combination Treatment With PEGASYS (Peginterferon Alfa-2a (40KD) Plus COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C.
Condition: Hepatitis C, Chronic
Interventions: Drug: peginterferon alfa-2a (40KD) [PEGASYS];   Drug: peginterferon alfa-2a (40KD) [PEGASYS];   Drug: ribavirin [Copegus];   Drug: ribavirin [Copegus]

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services